Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 40473-07-2 | MDL No. : | MFCD00088345 |
Formula : | C6H6BrNO | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | KMODISUYWZPVGV-UHFFFAOYSA-N |
M.W : | 188.02 | Pubchem ID : | 256810 |
Synonyms : |
|
Num. heavy atoms : | 9 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.17 |
Num. rotatable bonds : | 1 |
Num. H-bond acceptors : | 2.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 38.43 |
TPSA : | 22.12 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -5.3 cm/s |
Log Po/w (iLOGP) : | 2.22 |
Log Po/w (XLOGP3) : | 3.02 |
Log Po/w (WLOGP) : | 1.85 |
Log Po/w (MLOGP) : | 1.33 |
Log Po/w (SILICOS-IT) : | 2.04 |
Consensus Log Po/w : | 2.09 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -3.34 |
Solubility : | 0.0868 mg/ml ; 0.000462 mol/l |
Class : | Soluble |
Log S (Ali) : | -3.15 |
Solubility : | 0.133 mg/ml ; 0.000709 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -3.01 |
Solubility : | 0.185 mg/ml ; 0.000986 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.88 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
44% | at 20 - 165℃; for 15 h; | [Referential Example 21]; 6-Methoxypyridine-2-carbonitrile; Copper(I) cyanide (2.68 g) was added to 2-bromo-6-methoxypyridine (5.62 g) in N,N-dimethylformamide (112 mL) at room temperature, followed by stirring at 165°C for 15 hours. The resultant mixture was cooled in air. Water and ethyl acetate was added to the mixture. The insoluble matter that was formed in the mixture was filtered by Celite. The filtrate was partitioned between water and ethyl acetate. The organic layer was dried over sodium sulfate anhydrate, followed by filtration. The solvent was evaporated under reduced pressure. The residue was subjected to silica gel column chromatography (hexane - ethyl acetate), to thereby give the title compound as a solid substance (1.78 g, 44percent) .1H-NMR(400MHz,CDCl3)δ: 3.96(3H,s), 6.95-6.98(1H,m), 7.29-7.31(1H,m), 7.64-7.67(1H,m). MS (EI)m/z: 134 (M+) . |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
39% | at 20 - 100℃; for 16 h; | Synthesis of 6-methoxypicolinonitrile:To a stirred solution of 2-bromo-6-methoxypyridine (5.0 g, 26.59 mmol) in DMF (50 mL) was added Cu(I)cyanide (7.14 g, 79.77 mmol) at room temperature. The resulting reaction mixture was heated at 100 °C and stirred for 16 h. The reaction mixture was diluted with water, filtered through a pad of celite and the filtrate was extracted with EtOAc. Combined organic layer was dried over sodium sulphate, filtered and concentrated in vacuo to obtain the crude product. The crude material was purified by silica gel column chromatography to afford 6-methoxypicolinonitrile (1.4 g, 39percent) as white solid. 1H-NMR (DMSO d6, 400 MHz): δ 7.94 (t, 1H), 7.64 (d, 1H), 7.18 (d, 1H), 3.92 (s, 3H); LC-MS: 99.14percent; 135.8 (M++l); (column; X-bridge C-18, (50x3.0 mm, 3.5μ); RT 3.31 min. 0.1percent Aq TFA: ACN; 0.8 ml/min); TLC: 10percent EtOAc/Hexane (Rf: |
39% | at 100℃; for 16 h; | Synthesis of 6-methoxypicolinonitrile [0524] To a stirred solution of 2-bromo-6-methoxypyridine (5.0 g, 26.59 mmol) in DMF (50 mL) was added Cu(I)cyanide (7.14 g, 79.77 mmol) at room temperature. The resulting reaction mixture was heated at 100 °C and stirred for 16 h. The reaction mixture was diluted with water, filtered through a pad of celite and the filtrate was extracted with EtOAc. Combined organic layer was dried over sodium sulphate, filtered and concentrated in vacuo to obtain the crude product. The crude material was purified by silica gel column chromatography to afford 6-methoxypicolinonitrile (1.4 g, 39percent) as white solid. 1H-NMR (DMSO d6, 400 MHz): δ 7.94 (t, IH), 7.64 (d, IH), 7.18 (d, IH), 3.92 (s, 3H); LC-MS: 99.14percent; 135.8 (M++l); (column; X-bridge C-18, (50x3.0 mm, 3.5μ); RT 3.31 min. 0.1percent Aq TFA: ACN; 0.8 ml/min); TLC: 10percent EtOAc/Hexane (Rf: 0.3). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
89% | at 120℃; for 19 h; | [Referential Example 20] ;2-Bromo-6-methoxypyridine; In an argon atmosphere, sodium methoxide (1.82 g) was added to 2,6-dibromopyridine (8.0 g) in toluene (120 mL), followed by stirring at 120°C for 13 hours. Subsequently, sodium methoxide (0.728 g) was added to the mixture, followed by stirring at 120°C for 6 hours. The mixture was cooled in air. The reaction mixture was partitioned between water and ethyl acetate. The organic layer was dried over sodium sulfate anhydrate, followed by filtration. The solvent was evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane - ethyl acetate), to thereby give the title compound in an oily substance (5.64 g, 89percent).1H-NMR(400MHz,CDCl3)δ: 3.93(3H,s), 6.68(1H,d,J=8.0Hz), 7.05(1H,d,J=7.2Hz), 7.39-7.42(1H,m). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
7 g | at 15 - 25℃; for 3 h; | Step A 2-bromo-6-methoxypyridine (3a) To a solution of sodium metal (1.5 g, 62 mmol) in methanol (200 mL) stirred at room temperature for 10 min was added 2,6-dibromopyridine (10 g, 46 mmol). The resulting solution was stirred at room temperature for 3 h. The reaction mixture was quenched with dilute HCl and then extracted with dichloromethane. The combined organic layer was washed with water, brine successively, dried over anhydrous Na2SO4; filtered and concentrated under reduced pressure. The resulting crude product was purified by column by eluting with 5percent ethyl acetate in petroleum ether (v/v) to afford 2-bromo-6-methoxypyridine (7 g). MM-ESI+APCI [M+H]+m/z 187.8. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
42.9% | Stage #1: With 2,2,6,6-tetramethyl-piperidine; n-butyllithium In tetrahydrofuran; hexanes at -78℃; Inert atmosphere Stage #2: at -78 - 20℃; for 3 h; Stage #3: With water In tetrahydrofuran; hexanes; ethyl acetateAcidic aqueous solution |
Preparation 21 : 2-methoxy-6-(4,4,5,5-tetramethyl-[1 ,3,2]dioxaborolan-2-yl)- nicotinamide; Step 1 : ψ-bromo^-methoxy-nicotinic acid; A solution of 2,2,6,6-tetramethylpiperidine (0.766 g, 5.32 mmol) in tetrahydrofuran (5 mL) was cooled to -78°C under nitrogen. 2.5M n-butyllithium in hexanes (2.34 ml_, 0.375 g, 5.85 mmol) and the mixture was stirred at -780C for 30 min. To the reaction mixture was added a solution of 2-bromo-6-methoxypridine (1.00 g, 5.32mmol) in tetrahydrofuran (5 mL) dropwise. The reaction was stirred at -78°C for 1 h. After this time, an excess of dry ice was added to the reaction mixture and the reaction was allowed to warm to room temperature for 3 h. To the mixture was added water and ethyl acetate, the layers were separated. The aqueous layer was acidified to pH 4. The aqueous layer was extracted 3 times with ethyl acetate. The combined organic layers were washed with brine, dried over magnesium sulfate, filtered, and concentrated to an off-white solid (0.530 g, 42.9 percent) 1 H NMR (500 MHz, DMSO-d6) δ ppm 2.52 (2 H, br. s.), 3.32 (1 H, br. s.), 3.92 (1 H, m), 3.90 (1 H, d, J=2.9 Hz), 8.03 (1 H, d, J=7.8 Hz). |
[ 89466-18-2 ]
6-Bromo-2-methoxypyridin-3-amine
Similarity: 0.88
[ 1802489-60-6 ]
(6-Bromo-2-methoxypyridin-3-yl)methanol
Similarity: 0.86
[ 1802489-58-2 ]
(6-Bromo-2-methoxypyridin-3-yl)methanamine
Similarity: 0.82
[ 1805208-46-1 ]
6-Bromo-3-(bromomethyl)-2-methoxypyridine
Similarity: 0.81
[ 1060810-41-4 ]
2-Bromo-6-methoxynicotinaldehyde
Similarity: 0.80
[ 89466-18-2 ]
6-Bromo-2-methoxypyridin-3-amine
Similarity: 0.88
[ 1802489-60-6 ]
(6-Bromo-2-methoxypyridin-3-yl)methanol
Similarity: 0.86
[ 1802489-58-2 ]
(6-Bromo-2-methoxypyridin-3-yl)methanamine
Similarity: 0.82
[ 1805208-46-1 ]
6-Bromo-3-(bromomethyl)-2-methoxypyridine
Similarity: 0.81
[ 1060810-41-4 ]
2-Bromo-6-methoxynicotinaldehyde
Similarity: 0.80
[ 89466-18-2 ]
6-Bromo-2-methoxypyridin-3-amine
Similarity: 0.88
[ 1802489-60-6 ]
(6-Bromo-2-methoxypyridin-3-yl)methanol
Similarity: 0.86
[ 1802489-58-2 ]
(6-Bromo-2-methoxypyridin-3-yl)methanamine
Similarity: 0.82
[ 1805208-46-1 ]
6-Bromo-3-(bromomethyl)-2-methoxypyridine
Similarity: 0.81
[ 1060810-41-4 ]
2-Bromo-6-methoxynicotinaldehyde
Similarity: 0.80